Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
2.4K
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

140
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
140
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

6.1K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.1K
Pharmacodynamics: Overview and Principles01:21

Pharmacodynamics: Overview and Principles

1.0K
Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
1.0K
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

492
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
492
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

12.0K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
12.0K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

USP7 at the Crossroads of Ubiquitin Signaling, Cell Cycle, and Tumorigenesis.

Molecules (Basel, Switzerland)·2025
Same author

Alzheimer's Disease Etiology Hypotheses and Therapeutic Strategies: A Perspective.

International journal of molecular sciences·2025
Same author

Triazole-imidazo[1,2-<i>b</i>]pyrazoles Able to Counteract Melanoma Cell Survival Without Compromising the Viability of Healthy Keratinocytes.

International journal of molecular sciences·2025
Same author

Targeting Ubiquitin-Specific Protease 7 with Novel 5-Amino-Pyrazole Inhibitors: Design, Synthesis, and Biological Evaluation.

ChemMedChem·2025
Same author

Computational Methods for the Discovery and Optimization of TAAR1 and TAAR5 Ligands.

International journal of molecular sciences·2024
Same author

A Proteomics Approach Identifies RREB1 as a Crucial Molecular Target of Imidazo-Pyrazole Treatment in SKMEL-28 Melanoma Cells.

International journal of molecular sciences·2024

相关实验视频

Updated: Jun 17, 2025

Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control
07:13

Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control

Published on: May 24, 2024

445

PDE4D:一个多用途的药理目标

Matteo Lusardi1, Federica Rapetti1, Andrea Spallarossa1

  • 1Department of Pharmacy (DIFAR), University of Genoa, Viale Benedetto XV 3, 16132 Genova, Italy.

International journal of molecular sciences
|August 10, 2024
PubMed
概括

选择性PDE4D抑制剂在治疗神经退行性疾病 (如阿尔茨海默氏症和帕金森症) 以及某些癌症方面表现有前途. 本综述详细介绍了未来药物开发的已识别的抑制剂.

科学领域:

  • 生物化学 生物化学
  • 神经科学是一个神经科学.
  • 在瘤学瘤学.

背景情况:

  • 固酶4 (PDE4) 酶调节周期性腺单酸盐 (cAMP) 水解,影响至关重要的生理功能.
  • 固酶4D (PDE4Ds) 特别涉及认知过程,记忆和癌症发展.
  • PDE4D的失调与神经退行性疾病和癌症进展有关.

研究的目的:

  • 审查已识别的选择性PDE4D抑制剂 (PDE4Dis).
  • 为开发针对PDE4D的新型化合物提供药物化学见解.
  • 探索PDE4Dis在神经疾病和瘤学中的治疗潜力.

主要方法:

  • 对已识别的PDE4D抑制剂的文献综述.
  • 对PDE4Dis的结构-活性关系的分析.
  • 基于现有研究的治疗应用的评估.

主要成果:

  • PDE4Dis代表了阿尔茨海默氏症,帕金森症和多发性硬化症的潜在治疗策略.
  • 抑制PDE4D正在研究用于治疗肝细胞癌和乳腺癌.
  • 该审查整合了用于药物开发的PDE4Dis信息.
关键词:
卡特科尔分子部分.药物设计 药物设计神经退行性疾病的神经退行性疾病基化酶 4 基化酶基化酶4D是一种4D化酶.

更多相关视频

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog
08:37

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog

Published on: November 5, 2014

9.9K
Mapping the Cellular Distribution of an Optogenetic Protein Using a Light-Stimulation Grid
08:49

Mapping the Cellular Distribution of an Optogenetic Protein Using a Light-Stimulation Grid

Published on: January 26, 2024

206

相关实验视频

Last Updated: Jun 17, 2025

Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control
07:13

Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control

Published on: May 24, 2024

445
Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog
08:37

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog

Published on: November 5, 2014

9.9K
Mapping the Cellular Distribution of an Optogenetic Protein Using a Light-Stimulation Grid
08:49

Mapping the Cellular Distribution of an Optogenetic Protein Using a Light-Stimulation Grid

Published on: January 26, 2024

206

结论:

  • 选择性PDE4D抑制剂为神经退行性疾病和特定癌症提供了一个有希望的治疗途径.
  • 需要进一步的药物化学努力,以优化PDE4Di的临床用途属性.
  • 准PDE4D可以解决神经学和瘤学的未满足的医疗需求.